Synthesis and biological evaluation of novel 2-(1H-imidazol-4-yl)cyclopropane carboxylic acids: Key intermediates for H3 histamine receptor ligands

Bioorganic and Medicinal Chemistry Letters

Volumn 12, Issue 24, 2002, Pages 3561-3563

  Braa, Miguel F ^a   Guisado, Cristina ^a   Fernando Alguacil, Luis ^a   Garrido, Elisa ^a   Pérez García, Carmen ^a   Ruiz Gayo, Mariano ^a  

^a UNIVERSIDAD SAN PABLO CEU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYLIC ACID DERIVATIVE; HISTAMINE H3 RECEPTOR; ANTIHISTAMINIC AGENT; CARBOXYLIC ACID; CYCLOPROPANE DERIVATIVE; HISTAMINE DERIVATIVE; LIGAND;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING ASSAY; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; NONHUMAN; RAT; STEREOCHEMISTRY; STRUCTURE ACTIVITY RELATION; ANIMAL; BRAIN LEVEL; DRUG EFFECT; METABOLISM; RADIOASSAY; SYNTHESIS;

ANIMALS; BRAIN CHEMISTRY; CARBOXYLIC ACIDS; CYCLOPROPANES; HISTAMINE ANTAGONISTS; LIGANDS; METHYLHISTAMINES; RADIOLIGAND ASSAY; RATS; RECEPTORS, HISTAMINE H3; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0036889978     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(02)00793-X     Document Type: Article

References (21)

1. Hill S.J., Ganellin C.R., Timmerman H., Schwartz J.C., Shankley N.P., Young J.M., Schunack W., Levi R., Haas H.L. Pharmacol. Rev. 49:1997;253.
2. Oda T., Morikawa N., Saito Y., Masuho Y., Matsumoto S. J. Biol. Chem. 275:2000;36781.
3. Arrang J.M., Garbarg M., Schwartz J.C. Neuroscience. 23:1987;149.
4. Schilicker E., Malinowska B., Kathmann M., Göthert M. Fundam. Clin. Pharmacol. 8:1994;128.
5. Leurs, R., Vollinga, R. C., Timmerman, H. In Progress in Drug Research, Jacker, E., Ed., Birkhausser Verlag. Basel, 1995, pp 107-165.
6. (a) Arrang J.M., Garbarg M., Lancelot J.C., Lecomte J.M., Pollard H., Robba M.F., Schunack W., Schwartz J.C. Nature. 1987, 327, 117.
7. (b) Lipp R., Arrang J.M., Garbarg M., Luger P., Schwartz J.C., Schunack W. J. Med. Chem. 1992, 35, 4434.
8. (c) Shih N.Y., Lupo A.T. Jr., Aslanian R., Orlando S., Piwinski J.J., Green M.J., Ganguly A.K., Clark M.A., Tozzi S., Kreutner W., Hey J.A. J. Med. Chem. 1995, 38, 1593.
9. (a) Arrang, J. M.; Garbarg, M.; Schunack, W.; Schwartz, J. C.; Lipp, R. WO 214058, 1987.
10. (b) De Esch, I. J. P.; Vollinga, R. C.; Goubitz, K.; Schenck, H.; Appelberg, U.; Hacksell, U.; Lemstra, S.; Zuiderveld, O. P.; Hoffmann, M.; Leurs R.; Menge W. M. P. B.; Timmerman H. J. Med. Chem. 1999, 42, 1115.
11. (a) Tedford C.E., Phillips J.G., Gregory R., Pawlowski G.P., Fadnis L., Khan M.A., Ali S.M., Handley M.K., Yates S.L. J. Pharm. Exp. Ther. 1999, 289, 1160.
12. (b) Ali S.M., Tedford C.E., Gregory R., Handley M.K., Yates S.L., Hirth W.W., Phillips J.G. J. Med. Chem. 1999, 42, 903.
13. The cis allylic alcohols 1b,d were prepared utilizing standard literature procedures.
14. Doyle M.P., Austin R.E., Bailey A.S., Dwyer M.P., Dyatkin A.B., Kalinin A.V., Kwan M.M.Y., Liras S., Oalmann C.J., Pieters R.J., Protopopova M.N., Raab C.E., Roos G.H.P., Zhou Q.L., Martin S.F. J. Am. Chem. Soc. 117:1995;5763.
15. (a) Regitz M., Hocker J., Liedhegeuer A. Org. Synth. Coll. Vol. V. 1988;179 (b) Blankley C.J., Sauter F.J., House H.O. Org. Synth. Coll. Vol. V. 1988;258.
16. (a) Regitz M., Hocker J., Liedhegeuer A. Org. Synth. Coll. Vol. V. 1988;179 (b) Blankley C.J., Sauter F.J., House H.O. Org. Synth. Coll. Vol. V. 1988;258.
17. Collado, I., Pedregal, C., Marcos, A. WO 0075102, 2000.
18. (a) Van Leusen A.M., Wildeman J., Oldenziel O.H. J. Org. Chem. 42:1977;1153 (b) Sisko J., Kassick A.J., Mellinger M., Filan J.J., Allen A., Olsen M.A. J. Org. Chem. 65:2000;1516.
19. (a) Van Leusen A.M., Wildeman J., Oldenziel O.H. J. Org. Chem. 42:1977;1153 (b) Sisko J., Kassick A.J., Mellinger M., Filan J.J., Allen A., Olsen M.A. J. Org. Chem. 65:2000;1516.
20. Anantharamaiah G.M., Sivanandaiah K.M. J. Chem. Soc., Perkin Trans. 1. 490:1977.
21. Arrang J.M., Roy J., Morgat J.L., Schunack W., Schwartz J.C. Eur. J. Pharmacol. 188:1990;219.